Drugs

Pfizer amps up push into obesity treatments with $4.9B deal for Metsera

The COVID-19 vaccine and treatment maker said Monday that it will pay $47.50 in cash for each share of development-stage drugmaker Metsera. That represents a premium of more than 42% to Metsera’s closing price last Friday.
Melanotan-II: Why the viral ‘Barbie drug’ is so risky

TikTok and Instagram influencers have been peddling the ‘Barbie drug’ to help you tan. But melanotan-II, as it’s called officially, is a solution that’s too good to be true.
B.C. court tosses $1.2M lawsuit against doctor claiming drug caused compulsive gambling and shopping habits

The patient had racked up $220,000 in casino losses and bought 25 Louis Vuitton bags, but the judge said it was unclear whether Abilify was the cause of these behaviours.
Pharmacogenetics and the boy who cried revolution

Pharmacogenomics is often touted as revolutionary. Does the thought of a healthcare revolution make you feel exhausted? I suggest we take this revolution in increments, exactly the way this useful technology will impact patient care.
Recall: Health Canada pulls compounded semaglutide over unauthorized ingredient

Novo Nordisk Canada has also warned that compounded semaglutide may expose patients to health risks.

Trump’s Tylenol misinformation revives history of ‘mom blaming’ in autism, docs say